1.Clinical and genetic analysis of two children with Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language due to de novo variants of MEF2C gene.
Lulu YAN ; Danyan ZHUANG ; Youqu TU ; Yuxin ZHANG ; Yingwen LIU ; Yan HE ; Haibo LI
Chinese Journal of Medical Genetics 2023;40(10):1252-1256
OBJECTIVE:
To explore the clinical characteristics and genetic etiology for two children with Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language (MEDHSIL).
METHODS:
Two children who had visited the Ningbo Women and Children's Hospital on October 15, 2021 were selected as the study subjects. Whole exome sequencing (WES) was carried out for both patients. Candidate variants were verified by Sanger sequencing of their family members.
RESULTS:
The two children were respectively found to harbor a heterozygous c.138delC (p.Ile47Serfs*42) variant and a c.833del (p.L278*) variant of the MEF2C gene. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), both variants were predicted to be pathogenic (PVS1+PS2+PM2_Supporting).
CONCLUSION
The c.138delC and c.833del variants of the MEF2C gene probably underlay the pathogenesis of MEDHSIL in the two children. Above findings have enriched the mutational spectrum of the MEF2C gene and enabled genetic counseling for their families.
Child
;
Humans
;
Family
;
Genetic Counseling
;
Language
;
MEF2 Transcription Factors/genetics*
;
Muscle Hypotonia/genetics*
;
Neurodevelopmental Disorders
2.Effect of Xiaozhong Zhitong Ointment on MEF2 mRNA and protein expression in rats with gastrointestinal muscle injury.
China Journal of Orthopaedics and Traumatology 2019;32(6):578-581
OBJECTIVE:
To investigate the effect of Xiaozhong Zhitong Ointment(XZZTO) on remodeling and repair of skeletal muscle injury in rats based on the expression mechanism of microRNA.
METHODS:
The rat gastrocnemius injury model was established by blunt contusion model. The expression of MEF2 gene and protein in gastrocnemius muscle was detected by quantitative PCR at 4, 7, 14 and 21 days after injury with XZZTO. The mechanism of the effect of XZZTO on the muscle remodeling and repair of rat gastrocnemius contusion model was discussed.
RESULTS:
The expression level of MEF2 in the treatment group was significantly higher than that of the control group and model group, which further confirmed the important role of MEF2 in inducing skeletal muscle remodeling and repair process in the topical drugs. The expression of MEF2 increased at 7 days after injury and remained at a high level until 21 days after injury. Compared with the model group, the peak expression period was about 14 days, and then returned to the general state.
CONCLUSIONS
The expression level of MEF2 shows an upward trend. Even 21 days after injury, the expression of MEF2 dose not show a significant downward trend. It can be seen that XZZTO can promote the expression of MEF2. At the same time, XZZTO can regulate the regeneration and repair of skeletal muscle. Therefore, XZZTO can play a regeneration and repair role after skeletal muscle injury through gene regulation.
Animals
;
Contusions
;
Gastrointestinal Tract
;
Gene Expression Regulation
;
MEF2 Transcription Factors
;
genetics
;
Muscle, Skeletal
;
Ointments
;
Proteins
;
RNA, Messenger
;
Rats
3.Genetic analysis of a case with MEF2C deletion in association with 5q14.3 microdeletion syndrome.
Taocheng ZHOU ; Wei SU ; Dong LIANG ; Yanhong XU ; Yuanyuan LUO ; Guanglei TONG
Chinese Journal of Medical Genetics 2021;38(8):779-782
OBJECTIVE:
To explore the genetic basis for a child with febrile seizures.
METHODS:
Peripheral venous blood samples were taken from the child and his parents for the analysis of chromosomal karyotype and dynamic variant of the FMR1 gene. The family trio was also subjected to target capture and next generation sequencing (NGS) with a gene panel related to developmental retardation, mental retardation, language retardation, epilepsy and special facial features.
RESULTS:
The child was found to have a normal karyotype by conventional cytogenetic analysis (400 bands). No abnormal expansion was found with the CGG repeats of the FMR1 gene. NGS revealed that the child has carried a heterozygous c.864+1 delG variant of the MEF2C gene, which may lead to abnormal splicing and affect its protein function. The same variant was found in neither parent, suggesting that it has a de novo origin. Based on the American College of Medical Genetics and Genomics standards and guidelines, c.864+1delG variant of MEF2C gene was predicted to be pathogenic (PVS1+PS2+PM2).
CONCLUSION
MEF2C, as the key gene for chromosome 5q14.3 deletion syndrome which was speculated as a cause for febrile seizures, has an autosomal dominant effect. The c.864+1delG variant of the MEF2C gene may account for the febrile seizures in this patient.
Child
;
Chromosome Deletion
;
Chromosome Disorders
;
Epilepsy
;
Fragile X Mental Retardation Protein
;
Humans
;
Intellectual Disability/genetics*
;
Karyotyping
;
MEF2 Transcription Factors/genetics*
4.Regulation of myostatin promoter activity by myocyte enhancer factor 2.
Jia LI ; Jie DENG ; Junlin ZHANG ; De CHENG ; Huayan WANG
Chinese Journal of Biotechnology 2012;28(8):918-926
Myostatin (Mstn) is a member of the transforming growth factor-beta superfamily that functions as a negative regulator of skeletal muscle growth and differentiation in mammals. The transcriptional regulation of Mstn is controlled by multiple genes including MEF2, which raise the importance of identifying the binding sites of MEF2 on myostatin promoter region and mechanisms underlying. In this study, we investigated the transcriptional regulation of MEF2 on porcine Mstn promoter activity in C2C12 cells. Sequence analysis of the 1 969 bp porcine Mstn promoter region revealed that it contained three potential MEF2 motifs. Using a serial deletion strategy, we tested the activity of several promoter fragments by luciferase assay. Overexpression of MEF2C, but not MEF2A increased Mstn promoter activity in all the promoter fragments with MEF2 motifs by two to six folds, in both C2C12 myoblasts and myotubes. When we transfected exogenous MEF2C, Mstn mRNA level was also upregulated in C2C12 cells, but the protein level was only significantly increased in myotubes. Thus, we propose that MEF2C could modulate and restrain myogenesis by Mstn activation and Mstn-dependent gene processing in porcine. Our research also provided potential targets and an effective molecule to regulate Mstn expression and gave a new way to explore the functional performance of Mstn.
Animals
;
Cells, Cultured
;
Gene Expression Regulation
;
MEF2 Transcription Factors
;
Mice
;
Muscle, Skeletal
;
metabolism
;
Myoblasts
;
cytology
;
Myogenic Regulatory Factors
;
genetics
;
physiology
;
Myostatin
;
genetics
;
physiology
;
Promoter Regions, Genetic
;
Swine
5.Temporal regulation of transcription factor Mef2c by histone acetylases during cardiogenesis.
Chang PENG ; Wei-Hua ZHANG ; Bo PAN ; Wen-Qun GAO ; Jie TIAN
Chinese Journal of Contemporary Pediatrics 2014;16(4):418-423
OBJECTIVETo observe the temporal modification of transcription factor Mef2c by histone acetylases (HATs) P300, PCAF, and SRC1 during cardiogenesis and to provide a basis for investigating the pathogenesis of congenital heart disease.
METHODSThe normal heart tissues from embryonic mice (embryonic days 14.5 and 16.5) and neonatal mice (postnatal days 0.5 and 7) were collected. The binding of P300, PCAF, and SRC1 to Mef2c gene and level of histone H3 acetylation in the promoter region of Mef2c were evaluated by chromatin immunoprecipitation assays. Meanwhile, real-time PCR was used to measure the mRNA expression of Mef2c.
RESULTSP300, PCAF, SRC1 were involved in histone acetylation in the promoter region of Mef2c during cardiogenesis in mice, and binding of P300, PCAF, and SRC1 to the promoter of Mef2c varied significantly in different stages of cardiogenesis (P<0.01). The level of histone H3 acetylation and mRNA expression of Mef2c in the promoter region of Mef2c also varied significantly in different stages of cardiac development (P<0.01). The levels of acetylated H3, Mef2c mRNA, and HATs (P300, PCAF, SRC1) changed over time. They were highest on embryonic day 14.5 (P<0.01), decreased gradually with cardiac development, and were maintained at low levels after birth.
CONCLUSIONSThe mRNA expression of Mef2c varies during cardiogenesis in mice, which indicates that Mef2c plays an important role in the process of cardiac development. Meanwhile, histone acetylation in the promoter region of Mef2c is regulated temporally by HATs P300, PCAF, and SRC1.
Animals ; Female ; Gene Expression Regulation, Developmental ; Heart ; embryology ; Histone Acetyltransferases ; physiology ; MEF2 Transcription Factors ; genetics ; physiology ; Male ; Mice ; Promoter Regions, Genetic ; RNA, Messenger ; analysis
6.Expression of MEF2D on nasopharyngeal carcinoma tissues and its influence of prognostic.
Yongling LI ; Longcheng ZHANG ; Jiang NONG ; Shixia BIAN ; Zhen ZHAO ; Yi REN ; Xinran LIN ; Xiuwu BIAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(18):840-847
OBJECTIVE:
To explore the expression of MEF2D in NPC tissues, study the relationship between the expression and prognostic.
METHOD:
Specimens from 101 NPC patients who were follow-up visited 1 to 7 years were analyzed for MEF2D by using immunohistochemistry.
RESULT:
(1) The expression of MEF2D was higher in the higher clinical stage. (2) Density and Grey of MEF2D was negative correlated (|r| = 0.865, P < 0.01). (3) NPC patients' survival rate after therapies was 52.5%, the survival curve of 1th clinical stage was higher than 4th. (4) The survival curves of MEF2D stages were no statistical significance.
CONCLUSION
There's statistical significance of the MEF2D expression in clinical stages, but not in survival curve, which indicated that MEF2D concerned with invasion and metastatic of NPC.
Adult
;
Carcinoma
;
Carcinoma, Squamous Cell
;
metabolism
;
pathology
;
Female
;
Humans
;
Lymphatic Metastasis
;
MADS Domain Proteins
;
metabolism
;
MEF2 Transcription Factors
;
Male
;
Middle Aged
;
Myogenic Regulatory Factors
;
metabolism
;
Nasopharyngeal Carcinoma
;
Nasopharyngeal Neoplasms
;
metabolism
;
pathology
;
Neoplasm Staging
;
Prognosis
7.MEF2A gene and susceptibility to coronary artery disease in the Chinese people.
Hong YUAN ; Hong-wei LÜ ; Jing HU ; Shu-hua CHEN ; Guo-ping YANG ; Zhi-jun HUANG
Journal of Central South University(Medical Sciences) 2006;31(4):453-457
OBJECTIVE:
To explore MEF2A gene and susceptibility to coronary artery disease in the Chinese.
METHODS:
One hundred seventy-five coronary artery disease (CAD) patients and 228 normal subjects were recruited and their blood samples were amplified to detect sequences of all 11 exons of MEF2A gene by PCR. Single-strand conformational polymorphism (SSCP) analysis was used to detect the mutation. The amplified products were purified and sequenced.
RESULTS:
The tri-nucleotide (CAG) length polymorphism in the last coding exon of MEF2A in the Chinese was revealed and 4 of the 175 (2.3%) CAD samples containing 4 prolines were due to one proline deletion in MEF2A gene. But all the 228 normal subjects contained 5 prolines. The mutation in both 175 CAD samples and 228 normal subjects was not found in other exons.
CONCLUSION
The deletion mutation in exon 11 in MEF2A gene may be related to CAD susceptibility in the Chinese population.
Base Sequence
;
China
;
Coronary Artery Disease
;
genetics
;
Exons
;
genetics
;
Female
;
Gene Deletion
;
Genetic Predisposition to Disease
;
genetics
;
Humans
;
MEF2 Transcription Factors
;
Male
;
Middle Aged
;
Molecular Sequence Data
;
Mutation
;
Myogenic Regulatory Factors
;
genetics
;
Polymerase Chain Reaction
;
Polymorphism, Single-Stranded Conformational
;
Trinucleotide Repeats
9.Expression of Myocardial Specificity Markers MEF-2C and Cx43 in Rat Bone Marrow-derived Mesenchymal Stem Cells Induced by Electrical Stimulation In Vitro.
Min TANG ; Gang YANG ; Jian JIANG ; Xueling HE ; Huiming LI ; Mengying ZHANG ; Wenchao WU ; Xiaojing LIU ; Liang LI
Journal of Biomedical Engineering 2015;32(3):629-634
Bone marrow-derived mesenchymal stem cells (BMSCs) for repairing damaged heart tissue are a new kind of important treatment options because of their potential to differentiate into cardiomyocytes. We in this experiment investigated the effect of different electrical stimulation time on the expression of myocardial specificity gene and protein in rat bone marrow mesenchymal stem cells (rBMSCs) in vitro. The rBMSCs of second or third generation were randomly divided into three groups, i.e, electrical stimulation (ES) group, 5-Azacytidine (5-Aza) group and the control group. The rBMSCs in the ES groups with complete medium were exposed to 2 V, 2 Hz, 5 ms electrical stimulation for 0. 5 h, 2 h, 4 h, and 6 h respectively every day for 10 days. Those in the 5-Aza group were induced by 5-Aza (10 μmol/L) for 24 h, and then cultured with complete medium for 10 days. Those in the control group were only cultured with complete medium, without any treatment, for 10 days. The rBMSCs' morphological feature in each group was observed with inverted phase microscope. The mRNA expression of myocyte-specific enhancer factor 2C (MEF-2C) and connexin 43 (Cx43) were examined with Real-Time quantitative PCR and the protein expression of MEF-2C, Cx43 were detected with Western Blot method. The results showed that the mRNA expression level of the MEF-2C, Cx43 and the protein expression level of MEF-2C, Cx43 were significantly higher in the ES group and 5-Aza group than those in the relative control group (P < 0.05). It suggests that electrical stimulation could play a part of role in the induction of the rBMSCs to differentiate into the cariomyocyte-like cells in vitro and the effectiveness of the electrical stimulation with 2 h/d had the best in our experiment. But the mechanism how electrical stimulation promotes the differentiation of rBMSC into cardiomyocyte is still unclear.
Animals
;
Biomarkers
;
metabolism
;
Cell Differentiation
;
Cells, Cultured
;
Connexin 43
;
metabolism
;
Electric Stimulation
;
MEF2 Transcription Factors
;
metabolism
;
Mesenchymal Stromal Cells
;
cytology
;
metabolism
;
Myocytes, Cardiac
;
cytology
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
10.Myocyte Enhancer Factor-2A Gene Mutation and Coronary Artery Disease.
Chinese Medical Journal 2015;128(19):2688-2691
BACKGROUNDPremature ventricular contractions (PVCs) are common in the general population, and frequent PVCs may result in the poor quality of life or even the damage of cardiac function. We examined the efficacy and safety of a traditional Chinese medicine Wenxin Keli for the treatment of frequent PVCs among a relatively large Chinese cohort.
METHODSWe performed a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial. A total of 1200 eligible participants were randomly assigned in a ratio of 1:1 to receive Wenxin Keli or the placebo for 4 weeks. The primary and secondary endpoint was the change of PVC numbers and PVC-related symptoms after a 4-week treatment compared with baseline, respectively. In addition, vital signs, laboratory values, and electrocardiographic parameters were assessed in a safety analysis.
RESULTSAt the initial evaluation, no significant differences in the baseline characteristics were observed between the Wenxin Keli group and the placebo group. A smaller number of PVCs was observed after the 4-week treatment than at baseline, in both the Wenxin Keli group (5686 ± 5940 vs. 15,138 ± 7597 beats/d, P < 0.001) and the placebo group (10,592 ± 8009 vs. 14,529 ± 5929 beats/d, P < 0.001); moreover, the Wenxin Keli group demonstrated a significantly greater reduction in the frequency of PVCs than the placebo group (P < 0.001). In a full analysis set, patients in the Wenxin Keli group exhibited significantly higher total effective responses in the reduction of PVCs compared to those in the placebo group (83.8% vs. 43.5%,P < 0.001). The per-protocol analysis yielded similar results (83.0% vs. 39.3%,P < 0.001). Treatment with Wenxin Keli also demonstrated superior performance compared to the placebo with respect to PVC-related symptoms. No severe adverse effects attributable to Wenxin Keli were reported.
CONCLUSIONSWenxin Keli treatment effectively reduced the overall number of PVCs and alleviated PVC-related symptoms in patients without structural heart diseases and had no severe side effects.
Coronary Artery Disease ; genetics ; prevention & control ; Double-Blind Method ; Drugs, Chinese Herbal ; adverse effects ; therapeutic use ; Humans ; MEF2 Transcription Factors ; genetics ; Mutation ; genetics ; Myocardial Infarction ; drug therapy ; genetics ; Randomized Controlled Trials as Topic ; Ventricular Premature Complexes ; drug therapy ; genetics